3-Pyridinemethanamine,2-methoxy-(9CI)
|
|
3-Pyridinemethanamine,2-methoxy-(9CI) 속성
- 끓는 점
- 224.7±25.0 °C(Predicted)
- 밀도
- 1.090±0.06 g/cm3(Predicted)
- 저장 조건
- under inert gas (nitrogen or Argon) at 2–8 °C
- 산도 계수 (pKa)
- 7.60±0.29(Predicted)
- 외관
- Colorless to light yellow Liquid
안전
- 위험 및 안전 성명
- 위험 및 사전주의 사항 (GHS)
| 그림문자(GHS): |
|
||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 신호 어: | Warning | ||||||||||||||||||||||||||||
| 유해·위험 문구: |
|
||||||||||||||||||||||||||||
| 예방조치문구: |
|
3-Pyridinemethanamine,2-methoxy-(9CI) C화학적 특성, 용도, 생산
3-Pyridinemethanamine,2-methoxy-(9CI) 준비 용품 및 원자재
원자재
준비 용품
3-Pyridinemethanamine,2-methoxy-(9CI) 공급 업체
글로벌( 92)공급 업체
| 공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
|---|---|---|---|---|---|
| PharmaBlock Sciences (Nanjing),Inc. | 025-86918202 4000255188 |
sales@pharmablock.com | China | 5000 | 55 |
| Hangzhou Sage Chemical Co., Ltd. | +86057186818502 13588463833 |
info@sagechem.com | China | 10265 | 58 |
| Shanghai Topbiochem Technology Co., Ltd | 021-58170097 |
info@topbiochem.com | China | 9509 | 58 |
| Nanjing Norris-Pharm Technology Co., Ltd | 13901585132 |
sales@norris-pharm.com | China | 8869 | 55 |
| Jiangsu Aikon Biopharmaceutical R&D co.,Ltd. | 025-66113011 13913916777 |
cfzhang@aikonchem.com | China | 19902 | 55 |
| 9ding chemical ( Shanghai) Limited | 4009209199 |
sales@9dingchem.com | China | 18201 | 56 |
| SynAsst Chemical. | 021-60343070 |
China | 12731 | 55 | |
| JIANGYIN CANAL PHARMTECH CO.,LIMITED. | +86-18921203887 |
sales@canalpharm.net | China | 288 | 58 |
| Shanghai Hong-chuang Pharma Tech Co., Ltd. | 18151128828 |
hc-sales@foxmail.com | China | 2635 | 55 |
| Bide Pharmatech Ltd. | 400-164-7117 18317119277 |
product02@bidepharm.com | China | 40000 | 60 |
3-Pyridinemethanamine,2-methoxy-(9CI) 관련 검색:
2-(4-메틸페녹시)니코틴아미드 2-(4-클로로페녹시)니코틴아미드 2-페녹시피리딘-3-탄수화물 2-페녹시니코티나미드
N-(4-(4,5-Dichloroimidazolyl)phenyl)(2-(4-chlorophenoxy)(3-pyridyl))formamide
(2-(4-Chloro-2-methylphenoxy)(3-pyridyl))-N-(2-indol-3-ylethyl)formamide
N-(5,5-Dimethyl-7-oxo(4,5,6-trihydrobenzothiazol-2-yl))(2-phenoxy(3-pyridyl))formamide
(2-Phenoxy(3-pyridyl))-N-prop-2-ynylformamide
N-(5-Methylisoxazol-3-yl)(2-phenoxy(3-pyridyl))formamide
(2-(2,4-Dimethylphenoxy)(3-pyridyl))-N-(8-quinolyl)formamide
N-(2-Phenylethyl)(2-phenoxy(3-pyridyl))formamide
(2-(2,4-Dimethylphenoxy)(3-pyridyl))-N-(2-phenylethyl)formamide
N-(2-Indol-3-ylethyl)(2-phenoxy(3-pyridyl))formamide
(2-(2,4-Dimethylphenoxy)(3-pyridyl))-N-(5-methylisoxazol-3-yl)formamide
N3-(2-bromoethyl)-2-phenoxynicotinamide
(2-(4-Chlorophenoxy)(3-pyridyl))-N-(5-methylisoxazol-3-yl)formamide
N-(2,2-Diethoxyethyl)-N'-[(2-methoxy-3-pyridinyl)carbonyl]urea
2-Phenoxy-3-(([2-(phenylsulfonyl)ethyl]amino)carbonyl)pyridinium-1-olate




